These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35486842)

  • 1. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.
    de la Morena-Barrio ME; Suchon P; Jacobsen EM; Iversen N; Miñano A; de la Morena-Barrio B; Bravo-Pérez C; Padilla J; Cifuentes R; Asenjo S; Deleuze JF; Trégouët DA; Lozano ML; Vicente V; Sandset PM; Morange PE; Corral J
    Blood; 2022 Jul; 140(2):140-151. PubMed ID: 35486842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.
    de la Morena-Barrio ME; Martínez-Martínez I; de Cos C; Wypasek E; Roldán V; Undas A; van Scherpenzeel M; Lefeber DJ; Toderici M; Sevivas T; España F; Jaeken J; Corral J; Vicente V
    J Thromb Haemost; 2016 Aug; 14(8):1549-60. PubMed ID: 27214821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and clinical characterization of transient antithrombin deficiency: A new concept in congenital thrombophilia.
    Bravo-Pérez C; de la Morena-Barrio ME; de la Morena-Barrio B; Miñano A; Padilla J; Cifuentes R; Garrido P; Vicente V; Corral J
    Am J Hematol; 2022 Feb; 97(2):216-225. PubMed ID: 34800304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of antithrombin.
    Corral J; de la Morena-Barrio ME; Vicente V
    Thromb Res; 2018 Sep; 169():23-29. PubMed ID: 30005274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.
    Martínez-Martínez I; Ordóñez A; Navarro-Fernández J; Pérez-Lara A; Gutiérrez-Gallego R; Giraldo R; Martínez C; Llop E; Vicente V; Corral J
    Haematologica; 2010 Aug; 95(8):1358-65. PubMed ID: 20435622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
    Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
    Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the C-sheet in the maturation of N-glycans on antithrombin: functional relevance of pleiotropic mutations.
    Aguila S; Navarro-Fernández J; Bohdan N; Gutiérrez-Gallego R; de la Morena-Barrio ME; Vicente V; Corral J; Martínez-Martínez I
    J Thromb Haemost; 2014 Jul; 12(7):1131-40. PubMed ID: 24824609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.
    Aguila S; Martínez-Martínez I; Dichiara G; Gutiérrez-Gallego R; Navarro-Fernández J; Vicente V; Corral J
    PLoS One; 2014; 9(12):e114454. PubMed ID: 25485983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency.
    Kovács B; Bereczky Z; Oláh Z; Gindele R; Kerényi A; Selmeczi A; Boda Z; Muszbek L
    Am J Clin Pathol; 2013 Nov; 140(5):675-9. PubMed ID: 24124146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular structural analysis of a novel and de-novo mutation in the SERPINC1 gene associated with type 1 antithrombin deficiency.
    Wang TF; Dawson JE; Forman-Kay JD; Kahr WHA; Williams S; Chan AK; Kumar R
    Br J Haematol; 2017 May; 177(4):654-656. PubMed ID: 27098850
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital antithrombin deficiency in patients with splanchnic vein thrombosis.
    Baiges A; de la Morena-Barrio ME; Turon F; Miñano A; Alberto Ferrusquía J; Magaz M; Reverter JC; Vicente V; Hernández-Gea V; Corral J; García-Pagán JC
    Liver Int; 2020 May; 40(5):1168-1177. PubMed ID: 31885188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New genetic variant in the SERPINC1 gene: hereditary Antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling.
    Polyak ME; Zaklyazminskaya EV
    BMC Med Genet; 2020 Apr; 21(1):73. PubMed ID: 32252658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia.
    Orlando C; Heylen O; Lissens W; Jochmans K
    Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of SERPINC1 mutation on thrombotic phenotype in children with congenital antithrombin deficiency-first analysis of the International Society on Thrombosis and Haemostasis pediatric antithrombin deficiency database and biorepository.
    Kumar R; Bakeer N; Dawson J; Al-Mughairy A; Stanek J; Dunn A; Male C; Chan A; Williams S
    J Thromb Haemost; 2023 May; 21(5):1248-1257. PubMed ID: 36764659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.
    de la Morena-Barrio ME; Antón AI; Martínez-Martínez I; Padilla J; Miñano A; Navarro-Fernández J; Águila S; López MF; Fontcuberta J; Vicente V; Corral J
    Thromb Haemost; 2012 Mar; 107(3):430-7. PubMed ID: 22234719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis should be included in clinical practice when screening for antithrombin deficiency.
    Zeng W; Tang L; Jian XR; Li YQ; Guo T; Wang QY; Liu H; Wu YY; Cheng ZP; Hu B; Lu X; Yu JM; Deng J; Wang HF; Sun CY; Yang Y; Hu Y
    Thromb Haemost; 2015 Feb; 113(2):262-71. PubMed ID: 25298121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.
    Toderici M; de la Morena-Barrio ME; Padilla J; Miñano A; Antón AI; Iniesta JA; Herranz MT; Fernández N; Vicente V; Corral J
    PLoS One; 2016; 11(3):e0152159. PubMed ID: 27003919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of latent antithrombin in plasma from patients with antithrombin deficiency.
    de la Morena-Barrio M; Sandoval E; Llamas P; Wypasek E; Toderici M; Navarro-Fernández J; Rodríguez-Alen A; Revilla N; López-Gálvez R; Miñano A; Padilla J; de la Morena-Barrio B; Cuesta J; Corral J; Vicente V
    Thromb Haemost; 2017 May; 117(5):880-888. PubMed ID: 28229161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and functional characterization of rare compound heterozygous mutations in the SERPINC1 gene causing severe thrombophilia.
    Zhang K; Zhang H; Yu D; Pan J; Wang M; Xie H
    Gene; 2024 Mar; 897():148085. PubMed ID: 38104950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.